María Nayeli Acosta-Gutiérrez, Julia Del Carmen Rodríguez-García, David Manuel Miranda-Canteros, Célida Duque-Molina, Ernesto Krug-Llamas, Alma Belen Membrila-Torres, Beatriz Nohemi Aguirre-Mendoza, Itzel Valtierra-Martinez, Joel Bailon-Brito, Diego Salomón Balcón-Caro
{"title":"[Pierde Kilos,Gana Vida 战略、范围和前景]。","authors":"María Nayeli Acosta-Gutiérrez, Julia Del Carmen Rodríguez-García, David Manuel Miranda-Canteros, Célida Duque-Molina, Ernesto Krug-Llamas, Alma Belen Membrila-Torres, Beatriz Nohemi Aguirre-Mendoza, Itzel Valtierra-Martinez, Joel Bailon-Brito, Diego Salomón Balcón-Caro","doi":"10.5281/zenodo.13306787","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Pierde Peso, Gana Vida (Lose Weight, Gain Life) strategy is granted to patients with overweight or obesity, it started in 2022 with the purpose of ordering, integrating and making efficient actions in the care of overweight and obesity, however, its effectiveness is unknown.</p><p><strong>Objective: </strong>To analyze the changes in the following parameters: body weight, waist circumference, glucose, cholesterol and triglycerides in patients who received the strategy in the 35 IMSS state offices during the two semesters of 2022.</p><p><strong>Material and methods: </strong>A retrospective cohort study was conducted including 76,760 patients incorporated into the strategy in the two semesters of 2022. Trend analysis was performed before and after each semester of intervention. Analytical statistics were used for related samples with Student's t-test. SPPSS v25 software was used for data analysis.</p><p><strong>Results: </strong>Patients who received this strategy in each semester presented significant decrease in the parameters: body weight, waist circumference, glucose, cholesterol and triglycerides.</p><p><strong>Conclusions: </strong>The Pierde Peso, Gana Vida strategy makes the actions in obesity care efficient and allows achieving good results in the beneficiaries.</p>","PeriodicalId":94200,"journal":{"name":"Revista medica del Instituto Mexicano del Seguro Social","volume":"62 6","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The Pierde Kilos, Gana Vida strategy, scope and prospects].\",\"authors\":\"María Nayeli Acosta-Gutiérrez, Julia Del Carmen Rodríguez-García, David Manuel Miranda-Canteros, Célida Duque-Molina, Ernesto Krug-Llamas, Alma Belen Membrila-Torres, Beatriz Nohemi Aguirre-Mendoza, Itzel Valtierra-Martinez, Joel Bailon-Brito, Diego Salomón Balcón-Caro\",\"doi\":\"10.5281/zenodo.13306787\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The Pierde Peso, Gana Vida (Lose Weight, Gain Life) strategy is granted to patients with overweight or obesity, it started in 2022 with the purpose of ordering, integrating and making efficient actions in the care of overweight and obesity, however, its effectiveness is unknown.</p><p><strong>Objective: </strong>To analyze the changes in the following parameters: body weight, waist circumference, glucose, cholesterol and triglycerides in patients who received the strategy in the 35 IMSS state offices during the two semesters of 2022.</p><p><strong>Material and methods: </strong>A retrospective cohort study was conducted including 76,760 patients incorporated into the strategy in the two semesters of 2022. Trend analysis was performed before and after each semester of intervention. Analytical statistics were used for related samples with Student's t-test. SPPSS v25 software was used for data analysis.</p><p><strong>Results: </strong>Patients who received this strategy in each semester presented significant decrease in the parameters: body weight, waist circumference, glucose, cholesterol and triglycerides.</p><p><strong>Conclusions: </strong>The Pierde Peso, Gana Vida strategy makes the actions in obesity care efficient and allows achieving good results in the beneficiaries.</p>\",\"PeriodicalId\":94200,\"journal\":{\"name\":\"Revista medica del Instituto Mexicano del Seguro Social\",\"volume\":\"62 6\",\"pages\":\"1-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista medica del Instituto Mexicano del Seguro Social\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5281/zenodo.13306787\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica del Instituto Mexicano del Seguro Social","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.13306787","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:Pierde Peso, Gana Vida(减肥,增寿)战略针对超重或肥胖症患者,于2022年开始实施,目的是在超重和肥胖症护理方面采取有序、整合和高效的行动,但其有效性尚不清楚:目的:分析 2022 年两个学期期间,在 35 个 IMSS 州办公室接受该战略的患者的以下参数的变化情况:体重、腰围、血糖、胆固醇和甘油三酯:进行了一项回顾性队列研究,包括 2022 年两个学期纳入该战略的 76 760 名患者。每学期干预前后都进行了趋势分析。相关样本的分析统计采用学生 t 检验。数据分析使用 SPPSS v25 软件:结果:每学期接受该策略的患者在体重、腰围、血糖、胆固醇和甘油三酯等指标上都有显著下降:结论:"Pierde Peso, Gana Vida "战略使肥胖症护理行动变得高效,并使受益者取得了良好的效果。
[The Pierde Kilos, Gana Vida strategy, scope and prospects].
Background: The Pierde Peso, Gana Vida (Lose Weight, Gain Life) strategy is granted to patients with overweight or obesity, it started in 2022 with the purpose of ordering, integrating and making efficient actions in the care of overweight and obesity, however, its effectiveness is unknown.
Objective: To analyze the changes in the following parameters: body weight, waist circumference, glucose, cholesterol and triglycerides in patients who received the strategy in the 35 IMSS state offices during the two semesters of 2022.
Material and methods: A retrospective cohort study was conducted including 76,760 patients incorporated into the strategy in the two semesters of 2022. Trend analysis was performed before and after each semester of intervention. Analytical statistics were used for related samples with Student's t-test. SPPSS v25 software was used for data analysis.
Results: Patients who received this strategy in each semester presented significant decrease in the parameters: body weight, waist circumference, glucose, cholesterol and triglycerides.
Conclusions: The Pierde Peso, Gana Vida strategy makes the actions in obesity care efficient and allows achieving good results in the beneficiaries.